Skip to main content
Clinical Trials/CTRI/2025/02/080661
CTRI/2025/02/080661Not yet recruitingNot Applicable

Role of Invididualized Homoeopathic Medicine in Bronchial Asthma in cases of Young and Middle Age Group Patients.

Dr Vikas Chaudhary1 site in 1 country30 target enrollmentStarted: February 18, 2025Last updated:

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30
Locations
1
Primary Endpoint
1) it is expected that individualized homoeopathic Medicines selected will prove effective in the management of bronchial asthma.

Study Overview

Brief Summary

The present study is going to assess the role of individualized homoeopathic medicine in improving the symptoms of bronchial asthma and improvement in their healthy lifestyle..

A detailed case taking will be done using a standard homoeopathic case taking proforma, and after the diagnosis has been made the patient will be asked to fill the Asthma Control Test form for evaluation of the degree of disease, and maintaining all the previous and subsequent scores.

The individualized homoeopathic medicine will be selected on the basis of repertorial evaluation. The potency and dose will be selected according to the individual case and follow ups will be done in every 15 days. The Quality of life will also be assessed by the use of Modified Naranjo Algorithm.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • The sample includes patient of 18 to 60 years old age group of both sexes.
  • Patient fulfilling GINA(Global Initiative for Asthma) diagnostic criteria.
  • Informed and written consent.

Exclusion Criteria

  • Patients below the age of 18 and over the age of
  • Chronic systemic illness (e.g. Epilepsy, digestive, cardiovascular, renal and endocrine disorders.) 3) Use of medications for some other conditions or disease.
  • Patients with developed complications of asthma.

Outcomes

Primary Outcomes

1) it is expected that individualized homoeopathic Medicines selected will prove effective in the management of bronchial asthma.

Time Frame: 4weeks, 24weeks

2) The study will determine whether the quality of life of patients suffering From asthma can be improved by using individualized Homoeopathic medicine.

Time Frame: 4weeks, 24weeks

Secondary Outcomes

  • 1. If the results would be positive than a certain group of medicines can be Found out which would frequently prove useful in management of bronchial asthma(2.the study will go into public domain & will be beneficial for public.)

Investigators

Sponsor
Dr Vikas Chaudhary
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Vikas Chaudhary

State National Homoeopathic Medical College Lucknow

Study Sites (1)

Loading locations...

Similar Trials